NPS Pharmaceuticals, Inc. (NPSP)
$3.14
0.02 (+0.64%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $3.12 |
| Daily Range | $3.09 - $3.20 |
| 52-Week Range | $2.74 - $7.00 |
| Market Cap | $152.07M |
| P/E Ratio | 13.60 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 113,676 |
| Average Daily Volume | 254,000 |
NPSP
VS S&P 500 (SPY)
How do you think NPSP will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NPSP Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
NPSP News and Commentary
- 5 Cold Stocks Heating Up – The Motley Fool
- 5 Deathbed Stocks – The Motley Fool
- Wall Street's Buy List – The Motley Fool
- Closing NPSP (NPS Pharmaceuticals) underperform – Blog at The Motley Fool
- NPS Pharmaceuticals: What's for Dinner? – The Motley Fool
- Stocks on the Slide – The Motley Fool
Related News and Articles
- Dream Stocks for Biotech Investors – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
RSS Headlines
Fool UK
